A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients

China Spinal Cord Injury Network60 enrolled

Overview

To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following international standards and guidelines

Study Type

OBSERVATIONAL

Enrollment

Conditions

Spinal Cord Injuries

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female adult subjects, 18 to 60 years of age; 2. Have a clinical diagnosis of chronic SCI (defined as a history of ≥ 12 months suffering SCI); 3. The diagnosis of SCI was confirmed by MRI; and 4. Voluntarily signs and dates an Informed Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures Exclusion Criteria: 1. Severe head injury; 2. Is medically or mentally unstable according to the judgement of the Investigator; 3. History of Multiple Sclerosis or peripheral demyelinating disease; 4. Likely to have experimental therapy; 5. Any criteria, which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol

Locations (5)

First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

301 Orthopedic Hospital

Beijing, China

Second Affiliated Hospital of Third Military Medcial University

Chongqing, China

Buddhist Tzu Chi General Hospital

Hualien City, Taiwan

Outcomes

Primary Outcomes

The primary study outcomes will be the subject recruitment rate, the subject drip out rate, the number of missing values and the number of submitted incorrect values

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.